Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors - GlobeNewswire -BoardProspects

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

GlobeNewswire May 26 2022 BoardMoves

Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of Konstantin Konstantinov, Ph.D., a life sciences and bioprocessing industry expert. Dr. Konstantinov brings to the director role nearly 30 years of relevant experience, including his current position as Chief Technology Officer at Codiak BioSciences...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- NACD Directorship 100 Forum Focused on Reinvigorating America also published in GlobeNewswire
- D.C. United’s Danita Johnson Becomes First Woman To Join Buzzer’s Board Of Directors also categorized in BoardMoves
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Rand Logistics Announces Organizational and Corporate Governance Changes also published in GlobeNewswire
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire also published in GlobeNewswire
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned